The First 100 Cases of Parathyroid Tumor from Charity Hospital of Louisiana

Krementz, Edward T.; Yeager, Rodric M.; Hawley, W. D.; Weichert, Rudolph F.

doi:10.1097/00000658-197106010-00004

Cited by 50 publications

(14 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One cannot exclude the possibility that we are dealing with a coincidental finding. The prevalence of thyroid carcinomas depends on geographic factors (Cuello et al, 1969 ;Hakama, 1969;Fukunaga and Yatani, 1975), and at autopsy Mortensen (USA, 1955) and Kind (Switzerland, 1966) found 2.1 and 0.3% Ogburn and Block, 1956Ellenberg et al, 1962Fields et al, 1964Laing et al, 1969Heimann, 1970Krementz et al, 1971Trout et al, 1972Hajjar and Salti, 1973Malette et al, 1974Petro and Hardy, 1975Uehlinger, 1975Kairaluoma et al, 1976LiVolsi et al, 1976 of thyroid carcinomas respectively. Medullary thyroid carcinomas amounted for 6% of cases in Woolner et al's (1961) study.…”

Section: Discussionmentioning

confidence: 99%

Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma

Dralle

Altenähr

1979

Virchows Arch. A Path. Anat. and Histol.

View full text Add to dashboard Cite

An acidophilic pituitary adenoma associated with primary nodular parathyroid hyperplasia and a small papillary thyroid carcinoma was discovered at the autopsy of a 44 year old female acromegalic. The thyroid carcinoma showed evidence of lymphatic spread. Several etiopathogenetic mechanisms for the non-medullary thyroid carcinomata associated with Multiple Endocrine Neoplasia (MEN) have been postulated, since the follicular epithelium of the thyroid does not belong to the neural ectoderm derivates unlike the C-cells of the thyroid, the adenohypophysis and probably the parathyroid glands. Apart from genetic influence, or coincidence, one has to rule out carcinogenic exposure or hormonal influence. Clinically speaking, one should always consider whether malignant thyroid disease coexists with hyperplastic or neoplastic parathyroid tissue.

show abstract

Section: Discussionmentioning

confidence: 99%

Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma

Dralle

Altenähr

1979

Virchows Arch. A Path. Anat. and Histol.

View full text Add to dashboard Cite

show abstract

“…In two studies [6,10], the incidence of carcinoma of the breast in living women with primary hyperparathy roidism was reported to be II and 13%, respectively; however, in a third series [7], breast cancer was not observed. The incidence of breast cancer was only 3% in 34 autopsied cases in women [6], There are several other reports [12,13,15] of 1 or more cases of carcinoma of the breast associated with hyperparathyroidism.…”

Section: Observed Association Between Hyperparathyroidism and Neoplasmentioning

confidence: 95%

“…The results of these reports are summarized in tables I and II. The incidence of nonparathyroid malig nancy in patients with primary hyperparathyroidism is reported to be between 16 and 34% in surgical series [6,7,10,11] and 42% in an autopsy series [6]. In patients with primary hyperparathyroidism, the incidence of nonparathyroid malignancy appears to be greater in women than in men [6.…”

Section: Observed Association Between Hyperparathyroidism and Neoplasmentioning

confidence: 99%

“…11]. Malignancies have been reported to occur before, during, and after the diagnosis and treatment of parathyroid gland disease [10,II], Patients with primary hyperparathyroidism may have more than one nonparathyroid gland malignancy [6,7], A large number of different types of nonparathyroid can cers have been reported with primary hyperparathyroid- ■ ' S = Surgery; A = autopsy. b Some patients had more than one malignancy; basal cell carcino mas were generally excluded from these statistics.…”

Section: Observed Association Between Hyperparathyroidism and Neoplasmentioning

confidence: 99%

“…b One patient had thyrotoxicosis. 0 Autopsy series; other reports are from living patients or from a combination of living (75%) and autopsy cases (25%) (7). d One of these 5 patients had two different thyroid carcinomas.…”

Section: Observed Association Between Hyperparathyroidism and Neoplasmentioning

confidence: 99%

See 2 more Smart Citations

Is There an Association between Neoplasia and Primary or Secondary Hyperparathyroidism?

Kopple

Massry²

1988

Am J Nephrol

View full text Add to dashboard Cite

The Cost of Screening for Synchronous Thyroid Disease in Patients Presenting With Primary Hyperparathyroidism

Hollenbeak

Lendel

Beus

et al. 2007

Arch Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

To use decision analysis to compare the costs associated with minimally invasive parathyroidectomy (MIP) and bilateral neck exploration (BNE) in patients with primary hyperparathyroidism with regard to treatment of incidental synchronous thyroid disease. Design: We developed a decision tree model to evaluate the cost of managing thyroid pathology in primary hyperparathyroidism with the following 3 approaches: MIP, MIP with preoperative ultrasonography, and routine BNE with intraoperative thyroid evaluation. We tested the robustness of the optimal decision with sensitivity analyses. Setting: A tertiary care academic medical center. Main Outcome Measure: Total costs from a provider perspective. Results: Minimally invasive parathyroidectomy without an active search for thyroid abnormalities was determined to have the lowest expected cost ($5275 per patient). Parathyroid surgery with routine preoperative thyroid ultrasonography and further thyroid treatment as indicated had an expected cost of $5910 per patient. Bilateral neck exploration with intraoperative thyroid evaluation and treatment of the thyroid gland had an expected cost of $5916 per patient. Sensitivity analyses confirmed the robustness of the results across a reasonable range of surgical and imaging costs. Conclusions: Minimally invasive parathyroidectomy is not contraindicated on the basis of cost by an inability to screen for synchronous thyroid disease. In addition, ultrasonographic screening of the thyroid glands of patients undergoing MIP is not cost prohibitive and, in fact, is less costly than BNE. Ultrasonography has the added advantage of confirming the location of the offending parathyroid.

show abstract

The First 100 Cases of Parathyroid Tumor from Charity Hospital of Louisiana

Cited by 50 publications

References 17 publications

Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma

Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma

Is There an Association between Neoplasia and Primary or Secondary Hyperparathyroidism?

The Cost of Screening for Synchronous Thyroid Disease in Patients Presenting With Primary Hyperparathyroidism

Contact Info

Product

Resources

About